The Merck Digital Sciences Studio (MDS Studio) is a 10-month hands-on accelerator program providing mentorship, coaching, training, support community, and investment to enable the next generation of innovative technologies for drug discovery and development. Join MDS Studio on May 8 for light refreshments, learning and good conversation with MDS Studio’s 2nd Cohort of entrepreneurs that are changing the drug development landscape.
Agenda
1:00 - 1:20 - Introduction & Welcome
1:20 - 2:00 - Startup Quick Pitches
2:00 - 3:00 - Panel Discussion: Startup Mentality Meets Corporate Practice
3:00 - 4:30 - Open Networking
Merck Digital Sciences Studio Teams In Cohort 2
Aperture Bio Combining the study of proteins and their functions to facilitate the development of cancer drugs.
Ascent Bio Optimizing the search for candidate molecules with a pretrained, deep learning, API-oriented platform.
Brainify.AI Optimizing depression treatment through AI-driven precision psychiatry.
DANNCE.AI Transforming patient care and treatment via advanced 3D pose tracking AI to categorize patient mobility and behaviors.
DeepSeq.AI Decoding protein grammar to expedite lead discovery and ensure successful clinical entry.
E9 Genomics Making genomic insights instantaneous, simple, and accessible at every stage of research and therapeutic development.
Orbits Oncology Bring patients into the heart of cancer drug development and personalized medicine.
Prism.Bio Harnessing the power of cutting-edge generative AI to provide evidence-based insights.
Providentia Technologies Predicting drug toxicity early with synthetic cell membranes and machine learning algorithms.
ReadoutAI Assessing the future of preclinical and clinical trials, saving time and money for researchers and companies.
Serinus Biosciences Designing rational combination therapies using AI to overcome clinically-relevant disease resistance mechanisms
Vcreate Harnessing machine learning and high-throughput assays to discover potent T-cell receptors for currently untreatable cancers.
